New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 5, 2014
06:03 EDTKOOLCesca Therapeutics and Fortis Healthcare announce master collaboration
Cesca Therapeutics and Fortis Healthcare announced a master collaboration agreement that extends their important existing relationship. The agreement affirms Cesca's cellular therapy and cord blood bank at the Fortis Hospital Memorial Research Institute, or FMRI, in Gurgaon, renews the cord blood banking collaboration and launches the stem cell therapy services for hematological diseases across the Fortis network. The scope of services now provide for specific regenerative medicine programs including: cord blood banking services, point of care autologous cell therapy product and services, hematopoietic stem cell therapy services and oncological cellular therapy services.
News For KOOL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2014
06:09 EDTKOOLCesca Therapeutics files IDE application for no-option critical limb ischemia
Cesca Therapeutics has submitted an investigational device exemption application to the FDA for a pivotal multicenter study of the company's SurgWerks-CLI and VXP System for treating advanced stages of no-option lower limb critical limb ischemia. The IDE application is the result of two prior positive pilot and feasibility studies conducted in Italy and India, respectively, and collaborative pre-IDE feedback from the U.S. FDA. The primary endpoint is major amputation free survival at 12 months following enrollment.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use